Glenmark

Glenmark Pharma has received final USFDA approval for its Ranolazine extended-release tablets used for treatment of chronic angina. The drug Ranolazine extended-release tablets will be […]

Glenmark Pharmaceuticals has received final USFDA approval for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood. The approved product […]

Glenmark has receive final USFDA approval for Solifenacin Succinate Tablets in strengths of 5 mg and 10 mg. The drug Solifenacin Succinate is a generic […]

Glenmark Pharma has received final USFDA approval to market a generic version of AstraZeneca’s Nexium, used to treat acid reflux. The drug esomeprazole magnesium delayed-release […]

Glenmark Pharmaceuticals has received final USFDA approval for its generic version of BenzaClin gel used in the treatment of acne. The ointment gel Clindamycin and […]

Glenmark Pharma has received final USFDA approval for Sevelamer Hydrochloride tablets to market the same in US markets. The product is prescribe for controlling serum […]

Glenmark Pharmaceuticals has received final USFDA approval for generic version of Derma-Smoothe Topical Oil, used in the treatment of scalp psoriasis. The topical oil is […]

Glenmark Pharmaceuticals has received USFDA approval for Azelaic Acid gel used in treatment of acne. The gel Azelaic Acid Gel, 15 per cent, is a […]

Glenmark Pharmaceuticals has received final USFDA approval for Atovaquone, used for prevention and treatment of a type of pneumonia. The drug Atovaquone Oral Suspension USP […]